Board of Directors
Board of Directors
PathoQuest’s management team has significant experience and expertise with in vitro diagnostics and the development, validation and commercialization of metagenomic solutions for the identification of pathogens.
Rainer Metzger – Chairman
Rainer Metzger – Chairman
Rainer Metzger works as a business professional in the Life Science and Pharmaceutical Industry. He has led numerous co-development, commercialization, M&A, and licensing partnerships. Rainer has been in leading positions in precision medicine, initiating and managing partnerships and services for clinical trials, co-development, and commercialization with QIAGEN, ROCHE, DANAHER, and MEDICOVER establishing and running businesses with pharmaceutical companies. Rainer is acting as a board member for a series of Biotech companies in Europe and the US. He holds a Diploma in natural sciences and genetics and a Ph.D. in Biology and Pharmacology from the University of Heidelberg. →
Sascha Alilovic, MBA
Sascha Alilovic, MBA
Mr. Alilovic is a managing partner at SHS Gesellschaft für Beteiligungsmanagement a Tübingen-based investor specializing in healthcare investments. Before this, he held several high management positions as Head of Corporate Finance & Corporate Development at MorphoSys AG, Head of Deal Team and Senior Consultant M&A at Siemens AG, and Senior Director Corporate Finance, M&A at Clairfield SynCap Management. Mr. Alilovic holds a bachelor degree of Science in Computer Science from James Madison University, USA, and an MBA from the European Business School of Deutschland →
Christiane Honisch, PhD
Christiane Honisch, PhD
Dr. Honisch is currently SVP Head of Diagnostics at Evotec. She formerly was Head of Global Business Intelligence and Development at Eppendorf. Prior to this, she was the Director of Microbiology Markets at Illumina, Inc. and before the Director of Infectious Disease Research at Roche Molecular Diagnostics. Her team received the Roche Innovation Award in 2014. Previously she was key in the commercial use of nucleic acid based mass spectrometry for DNA sequencing and microbial analysis at Sequenom, Inc. Dr. Honisch received her Ph.D. in molecular biology and microbiology from the University Carolo-Wilheimina zu Braunschweig, Germany and the German National Center for Biotechnology (GBF) in the field of the diagnosis and typing of tuberculosis. →
Thierry Laugel, PhD, MBA
Thierry Laugel, PhD, MBA
Dr. Thierry Laugel, Ph.D. is a co-Founder and Managing Partner at Kurma Partners since 2009. He was previously Partner at AGF Private Equity, (2006 to 2009) and CDC Innovation (1998 to 2005). Before that, he worked for Flamel Technologies as Project Director for Pharmaceutical R&D (1997-1998) and Fournier Japan, as Coordinator of R&D programmes (1992 – 1996). He has served as Director or Board member in more than 20 companies. Dr. Laugel holds a Pharm.D, a Ph.D. in Pharmacology, and an M.B.A. from INSEAD. →
Jean-Pascal Beaufret
Jean-Pascal Beaufret
Mr. Beaufret is the Chief Financial Officer of NBN Co. Limited. He also served as a General Manager of Electrobanqueand. He was Executive in the Ministry of Finance, Deputy Secretary of the international department from 1986 to 1988 and, Deputy Secretary for monetary affairs from 1988 to 1994. He served as General Manager of the French tax administration office since 1997. Mr. Beaufret serves as a Member of the Advisory Board at Aurinvest. He has been Vice Chairman at Sequana S.A., since June 27, 2013, and has been its Independent Director since May 21, 2008. He served as Member of the Supervisory Board at Portigon AG since August 1, 2002. He is a graduate of HEC (Paris Business School) and of the ENA (French National School of Public Administration). →
Let’s Start Something New
Welcome to PathoQuest!